Ra Pharma (RARX) PT Raised to $35 at SunTrust Robinson Humphrey
Tweet Send to a Friend
SunTrust Robinson Humphrey analyst Edward Nash raised the price target on Ra Pharma (NASDAQ: RARX) to $35.00 (from $28.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
